Skip to main content
Monday, November 16, 2026Nov 16

Lawsuit claims new TennCare rates endanger hemophiliacs

audit-tenncare-paid-27m-over-7-years-dead-patients
lawsuit-new-tenncare-rates-endanger-hemophilia-pat

NASHVILLE, Tenn. – Pharmacies in Tennessee are accusing the state of breaking federal law and endangering people with bleeding disorders such as hemophilia by reducing reimbursements for prescription blood-clotting drugs through its Medicaid program.

Hemophilia is very rare, affecting about 20,000 people in the United States, according to the federal Centers for Disease Control and Prevention, and the drugs used to treat it are among the most expensive on the market, according to the Hemophilia Federation of America.

A lawsuit filed last week by specialty pharmacies and their wholesaler accuses TennCare of targeting clotting-factor pharmacies, based on a faulty survey, to save $12 million to $15 million annually.

“TennCare’s voluntary decision to save money by singling out clotting factor has placed the bleeding disorder community in great danger,” the lawsuit says.

TennCare spokeswoman Sarah Tanksley declined to comment, citing the pending litigation.